Thomas Bugge
6Patents
2h-index
8Co-inventors
40Inventor score
Filing activity: Sep 22, 2000 → Aug 25, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7947289B2 | Multimeric protein toxins to target cells having multiple identifying characteristics | Chemistry; Metallurgy | 3 | Active |
| US7468352B1 | Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors | Chemistry; Metallurgy | 2 | Expired |
| US8388933B2 | Multimeric protein toxins to target cells having multiple identifying characteristics | Chemistry; Metallurgy | 2 | Active |
| US9403872B2 | Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors | Chemistry; Metallurgy | 0 | Active |
| US8791074B2 | Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors | Chemistry; Metallurgy | 0 | Active |
| US10835593B2 | Modified anthrax toxin protective antigen | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.